Index NDX, S&P 500
P/E 39.66
EPS (ttm) 10.67
Insider Own 1.03%
Shs Outstand 81.60M
Perf Week 2.57%
Market Cap 34.40B
Forward P/E 31.16
EPS next Y 13.57
Insider Trans -1.57%
Shs Float 80.49M
Perf Month -5.81%
Income 887.87M
PEG 3.04
EPS next Q 2.86
Inst Own 89.80%
Short Float 3.40%
Perf Quarter -2.11%
Sales 3.90B
P/S 8.83
EPS this Y 12.25%
Inst Trans -1.41%
Short Ratio 3.94
Perf Half Y -17.28%
Book/sh 19.55
P/B 21.64
EPS next Y 13.32%
ROA 27.10%
Short Interest 2.74M
Perf Year -20.16%
Cash/sh 3.54
P/C 119.34
EPS next 5Y 13.04%
ROE 57.66%
52W Range 398.50 - 548.88
Perf YTD 2.31%
Dividend Est. -
P/FCF 42.57
EPS past 5Y 16.90%
ROI 41.43%
52W High -22.94%
Beta 1.50
Dividend TTM -
Quick Ratio 0.90
Sales past 5Y 10.23%
Gross Margin 61.01%
52W Low 6.15%
ATR (14) 12.62
Dividend Ex-Date -
Current Ratio 1.25
EPS Y/Y TTM 5.82%
Oper. Margin 28.93%
RSI (14) 43.87
Volatility 3.04% 2.97%
Employees 11000
Debt/Eq 0.62
Sales Y/Y TTM 6.46%
Profit Margin 22.78%
Recom 2.00
Target Price 526.09
Option/Short Yes / Yes
LT Debt/Eq 0.34
EPS Q/Q 13.00%
Payout 0.00%
Rel Volume 0.26
Prev Close 419.52
Sales Surprise 2.05%
EPS Surprise 9.04%
Sales Q/Q 5.84%
Earnings Feb 03 BMO
Avg Volume 694.67K
Price 422.99
SMA20 -2.79%
SMA50 -3.30%
SMA200 -7.87%
Trades
Volume 95,283
Change 0.83%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-02-24 Initiated
Leerink Partners
Outperform
$500
Jul-25-24 Initiated
BTIG Research
Buy
$580
Jan-30-24 Downgrade
Piper Sandler
Overweight → Neutral
$525
Dec-07-23 Initiated
Exane BNP Paribas
Outperform
$602
Dec-04-23 Upgrade
Cleveland Research
Neutral → Buy
Aug-02-23 Downgrade
Atlantic Equities
Overweight → Neutral
$610
Jul-25-22 Downgrade
Stifel
Buy → Hold
$415
Jul-21-22 Upgrade
Goldman
Neutral → Buy
$530 → $435
Jul-12-22 Initiated
Piper Sandler
Overweight
$440
May-05-22 Downgrade
BofA Securities
Buy → Neutral
$550 → $470
Feb-08-22 Initiated
Atlantic Equities
Overweight
$650
Nov-18-21 Initiated
Morgan Stanley
Overweight
Aug-05-21 Resumed
Credit Suisse
Outperform
$735
Jul-12-21 Downgrade
Guggenheim
Buy → Neutral
Feb-17-21 Initiated
Barclays
Overweight
$600
Sep-09-19 Initiated
Goldman
Neutral
$277
May-23-19 Initiated
Guggenheim
Buy
$276
Nov-02-18 Reiterated
BofA/Merrill
Buy
$275 → $235
May-07-18 Reiterated
Stifel
Buy
$215 → $225
Jan-16-18 Initiated
Piper Jaffray
Overweight
$200
Show Previous Ratings
Mar-18-25 02:50PM
Mar-12-25 03:08PM
09:28AM
Mar-11-25 07:22PM
Mar-05-25 11:30AM
11:15AM
Loading…
Feb-19-25 11:15AM
Feb-14-25 08:27AM
Feb-13-25 02:00PM
Feb-12-25 07:58AM
Feb-10-25 09:39AM
Feb-07-25 07:09AM
Feb-04-25 04:40PM
02:02AM
12:20AM
(Thomson Reuters StreetEvents)
Feb-03-25 07:33PM
(Morningstar Research) +11.13%
04:42PM
Loading…
04:42PM
04:02PM
(Investor's Business Daily)
11:51AM
11:42AM
11:31AM
11:05AM
10:54AM
09:51AM
09:30AM
07:40AM
06:46AM
(Associated Press Finance)
06:30AM
Feb-01-25 07:07AM
Jan-29-25 04:22PM
Jan-16-25 04:15PM
09:45AM
Loading…
Dec-26-24 09:45AM
Dec-20-24 04:02PM
Dec-19-24 10:09AM
Dec-13-24 08:45AM
Dec-09-24 06:58PM
07:30AM
Nov-27-24 09:00AM
Nov-21-24 07:30AM
Nov-07-24 08:44AM
Nov-06-24 04:11AM
Nov-05-24 09:53AM
Nov-01-24 01:24PM
03:05AM
03:01AM
(Thomson Reuters StreetEvents)
Oct-31-24 01:16PM
(Morningstar Research) -9.79%
01:15PM
09:30AM
07:40AM
06:41AM
(Associated Press Finance)
06:30AM
Oct-28-24 09:16AM
Oct-24-24 10:01AM
Oct-17-24 11:43AM
Oct-11-24 09:06AM
Oct-10-24 10:55AM
Oct-08-24 10:16AM
Oct-06-24 12:53PM
Sep-30-24 02:00PM
Sep-18-24 10:48PM
Sep-05-24 11:31AM
Aug-28-24 10:03AM
Aug-23-24 04:34PM
Aug-21-24 04:15PM
Aug-13-24 08:28AM
Aug-09-24 09:58AM
Aug-07-24 06:09AM
(Thomson Reuters StreetEvents)
Aug-06-24 09:47AM
09:30AM
07:40AM
06:36AM
(Associated Press Finance)
06:30AM
Aug-01-24 09:15AM
Jul-30-24 05:53PM
10:01AM
07:00AM
Jul-22-24 09:56AM
Jul-08-24 03:44AM
Jul-02-24 07:26AM
Jun-24-24 11:00AM
Jun-21-24 11:36AM
Jun-19-24 01:53PM
Jun-06-24 08:55AM
Jun-04-24 07:00AM
May-31-24 11:31AM
May-29-24 06:00AM
May-25-24 03:00PM
May-20-24 11:18AM
May-14-24 02:00PM
08:27AM
May-13-24 02:25PM
May-04-24 07:38AM
May-02-24 02:22PM
02:17PM
10:31AM
10:30AM
10:20AM
09:46AM
09:23AM
03:08AM
May-01-24 11:28PM
(Thomson Reuters StreetEvents) -5.02%
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MCKEON BRIAN P EVP, CFO and Treasurer Feb 14 '25 Option Exercise 0.00 1,162 0 32,119 Feb 18 09:44 PM Smith Martin Alexander Executive Vice President Feb 14 '25 Option Exercise 0.00 1,231 0 1,766 Feb 18 09:43 PM Schreck Michael Executive Vice President Feb 14 '25 Option Exercise 0.00 1,459 0 2,397 Feb 18 09:43 PM MAZELSKY JONATHAN JAY President and CEO Feb 14 '25 Option Exercise 0.00 2,747 0 84,505 Feb 18 09:43 PM Lane Michael Executive Vice President Feb 14 '25 Option Exercise 0.00 885 0 7,375 Feb 18 09:43 PM Johnson Michael Perkins Executive Vice President Feb 14 '25 Option Exercise 0.00 355 0 585 Feb 18 09:43 PM Hunt Nimrata Executive Vice President Feb 14 '25 Option Exercise 0.00 872 0 12,595 Feb 18 09:43 PM FENNELL GEORGE Executive Vice President Feb 14 '25 Option Exercise 0.00 304 0 8,480 Feb 18 09:42 PM Erickson Michael G Executive Vice President Feb 14 '25 Option Exercise 0.00 557 0 21,393 Feb 18 09:42 PM Erickson Michael G Executive Vice President Feb 11 '25 Option Exercise 67.85 1,544 104,760 20,836 Feb 12 05:04 PM FENNELL GEORGE Executive Vice President Feb 10 '25 Option Exercise 79.54 9,986 794,286 18,162 Feb 11 05:00 PM FENNELL GEORGE Executive Vice President Feb 07 '25 Option Exercise 79.54 1,256 99,902 8,176 Feb 11 05:00 PM FENNELL GEORGE Executive Vice President Feb 10 '25 Sale 462.53 9,986 4,618,862 8,176 Feb 11 05:00 PM FENNELL GEORGE Officer Feb 10 '25 Proposed Sale 463.46 9,966 4,618,863 Feb 10 05:52 PM SZOSTAK M ANNE Director Feb 07 '25 Sale 465.94 3,000 1,397,835 3,061 Feb 10 05:03 PM Margaret Anne Szostak Director Feb 07 '25 Proposed Sale 460.56 3,000 1,381,680 Feb 07 04:08 PM Vandebroek Sophie V. Director Nov 27 '24 Sale 420.44 344 144,630 905 Nov 29 05:00 PM Vandebroek Sophie V. Director Nov 27 '24 Proposed Sale 420.44 344 144,630 Nov 27 04:36 PM SZOSTAK M ANNE Director Sep 06 '24 Sale 469.37 500 234,686 0 Sep 09 04:18 PM M. Anne Szostak Director Sep 06 '24 Proposed Sale 469.78 500 234,890 Sep 06 04:36 PM Schreck Michael Executive Vice President Sep 01 '24 Option Exercise 0.00 164 0 961 Sep 04 08:20 PM Smith Martin Alexander Executive Vice President Sep 01 '24 Option Exercise 0.00 18 0 515 Sep 04 08:03 PM MCKEON BRIAN P EVP, CFO and Treasurer Aug 05 '24 Option Exercise 0.00 192 0 31,049 Aug 07 05:01 PM MAZELSKY JONATHAN JAY President and CEO Aug 05 '24 Option Exercise 0.00 384 0 81,903 Aug 07 05:00 PM Claflin Bruce L. Director May 17 '24 Sale 540.80 200 108,160 161 May 20 05:00 PM Vandebroek Sophie V. Director May 06 '24 Option Exercise 0.00 257 0 1,473 May 08 07:02 PM SZOSTAK M ANNE Director May 06 '24 Option Exercise 0.00 257 0 257 May 08 07:02 PM Kingsley Lawrence D Director May 06 '24 Option Exercise 0.00 339 0 8,883 May 08 07:02 PM ESSIG STUART Director May 06 '24 Option Exercise 0.00 257 0 1,974 May 08 07:01 PM COLLINS Asha Director May 06 '24 Option Exercise 0.00 257 0 779 May 08 07:01 PM Britt Irene Chang Director May 06 '24 Option Exercise 0.00 208 0 208 May 08 07:00 PM AYERS JONATHAN W Director May 06 '24 Option Exercise 0.00 257 0 265,651 May 08 07:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite